Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $26 | $42 | $70 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $8 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $8 | $3 | $3 |
| Total Curr. Assets | $14 | $34 | $45 | $73 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $9 | $9 | $9 | $9 |
| Intangibles | $93 | $59 | $59 | $59 |
| Long-Term Investments | $0 | $45 | $0 | $29 |
| Tax Assets | $0 | $0 | -$40 | -$29 |
| Other NC Assets | $0 | -$45 | $40 | $0 |
| Total NC Assets | $102 | $69 | $69 | $70 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $117 | $104 | $114 | $142 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $31 | $2 | $3 | $2 |
| Total Curr. Liab. | $36 | $6 | $5 | $4 |
| LT Debt | $0 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | -$0 | -$0 | -$0 |
| Deferred Tax Liab, NC | $7 | $6 | $6 | $5 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $6 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $1 |
| Total Liabilities | $43 | $12 | $11 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$201 | -$162 | -$130 | -$96 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $271 | $253 | $232 | $228 |
| Total Equity | $70 | $91 | $103 | $132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $1 | $1 | $1 |
| Total Liab. & Tot. Equity | $117 | $104 | $114 | $142 |
| Net Debt | -$3 | -$26 | -$41 | -$69 |